CS/CS/CS/HB 1481: Sickle Cell Disease Medications, Treatment, and Screening
GENERAL BILL by Health & Human Services Committee ; Health Care Appropriations Subcommittee ; Healthcare Regulation Subcommittee ; Driskell ; Campbell ; (CO-INTRODUCERS) Amesty ; Bartleman ; Joseph ; Woodson
Sickle Cell Disease Medications, Treatment, and Screening; Requires certain health care providers to notify primary care physicians of newborns & infants of certain screening results relating to sickle cell hemoglobin variants & to submit such results to DOH for specified purpose; requires such physicians to provide certain information to parents & guardians; requires DOH to establish & maintain sickle cell registry; authorizes parents & guardians to request to have their children removed from registry; requires AHCA to review sickle cell disease medications, treatments, & services for Medicaid recipients & develop written report, post report on its website, & submit copy of report to Governor, Legislature, & certain entities. APPROPRIATION: $1,332,159
Last Action: 5/2/2023 House - Laid on Table; companion bill(s) passed, see CS/CS/SB 1352 (Ch. 2023-258)
Bill Text: PDF
Bill History
| Date | Chamber | Action |
|---|---|---|
| 3/6/2023 | House |
• Filed |
| 3/7/2023 | House |
• 1st Reading (Original Filed Version) |
| 3/9/2023 | House |
• Referred to Healthcare Regulation Subcommittee • Referred to Health Care Appropriations Subcommittee • Referred to Health & Human Services Committee • Now in Healthcare Regulation Subcommittee |
| 3/20/2023 | House |
• Added to Healthcare Regulation Subcommittee agenda |
| 3/22/2023 | House |
• Favorable with CS by Healthcare Regulation Subcommittee |
| 3/24/2023 | House |
• Reported out of Healthcare Regulation Subcommittee • Laid on Table under Rule 7.18(a) • CS Filed • 1st Reading (Committee Substitute 1) |
| 3/27/2023 | House |
• Referred to Health Care Appropriations Subcommittee • Referred to Health & Human Services Committee • Now in Health Care Appropriations Subcommittee |
| 4/10/2023 | House |
• Added to Health Care Appropriations Subcommittee agenda |
| 4/12/2023 | House |
• Favorable with CS by Health Care Appropriations Subcommittee • Reported out of Health Care Appropriations Subcommittee |
| 4/13/2023 | House |
• Laid on Table under Rule 7.18(a) • CS Filed • Referred to Health & Human Services Committee • Now in Health & Human Services Committee • Added to Health & Human Services Committee agenda • 1st Reading (Committee Substitute 2) |
| 4/17/2023 | House |
• Removed from Meeting Agenda of Health & Human Services Committee |
| 4/23/2023 | House |
• Added to Health & Human Services Committee agenda |
| 4/24/2023 | House |
• Favorable with CS by Health & Human Services Committee • Reported out of Health & Human Services Committee |
| 4/25/2023 | House |
• Laid on Table under Rule 7.18(a) • CS Filed • Bill referred to House Calendar • 1st Reading (Committee Substitute 3) • Added to Second Reading Calendar |
| 5/2/2023 | House |
• Laid on Table; companion bill(s) passed, see CS/CS/SB 1352 (Ch. 2023-258) |
